Suppression of Chrebp in vitro and in vivo leads to a p53-dependent reduction in tumor growth [88], which is consistent with evidence that ATP citrate inhibitors suppress tumor cell proliferation [103]. This evidence concerns the gene TP53 and neoplasm.